Abstract
Introduction: HPV detection in gynaecological samples currently provides key data in cervical pathology for diagnostic and management decisions. At present HC2 is the most clinically proven method for this purpose. Methods: Comparative study of HPV-HR detection between HC2 and Cervista™. Results: The concordance between the two methods is 96.4%. The sensitivity of Cervista™ for CIN2+ is 98.3% and specificity exceeds 98.4%. Conclusions: We conclude that Cervista™ is an appropriate method for the detection of HPV-HR in gynecological samples for screening and clinical purposes. © 2011 SEAP y SEC.
Original language | English |
---|---|
Pages (from-to) | 191-194 |
Journal | Revista Espanola de Patologia |
Volume | 44 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Oct 2011 |
Keywords
- Cervical pathology
- Detection
- Human papilomavirus (HPV)
- Screening